多发性硬化或阿尔茨海默病中的BP180自身抗体靶向表位与大疱性类天疱疮不同
神经系统疾病患者大疱性类天疱疮(BP)风险增加,其自身抗体靶向皮肤基底膜蛋白BP180,该蛋白也表达于脑。本研究发现多发性硬化(MS)和阿尔茨海默病(AD)患者中BP180自身抗体的表位谱与BP患者不同,且罕见结合天然构象BP180,这解释了这些自身抗体不能引起皮肤症状,提示仅BP180自身抗体不足以在MS和AD患者中诱发BP。
要点
- MS血清中53.6%(n=56)免疫印迹识别全长BP180,但BP180非胶原16A ELISA仅7.7%(n=143)阳性。
- MS和AD患者IgG自身抗体靶向BP180胞内及胞外中段区域,而非非胶原16A域和胞外远端。
- 间接免疫荧光中8.1%MS血清识别皮肤基底膜,全长BP180 ELISA中7.5%MS和AD血清阳性。
核心结论
- MS和AD患者中BP180自身抗体表位谱与BP患者不同,且罕见结合天然构象BP180,这解释了其不能引起皮肤症状。
- 结果提示仅针对BP180的自身抗体不足以在MS和AD患者中诱导BP。
研究设计与样本
- 研究检测了MS患者血清(n=56)和MS样本(n=143)等,采用免疫印迹、ELISA和间接免疫荧光分析及表位映射。
主要发现
- 免疫印迹中53.6%的MS血清(n=56)对全长BP180有IgG反应性。
- BP180非胶原16A ELISA中仅7.7%的MS样本(n=143)阳性。
- 用覆盖BP180多肽的13个融合蛋白进行表位映射显示,MS和AD患者IgG自身抗体靶向BP180胞内和胞外中段区域,而非非胶原16A域和胞外远端。
- 间接免疫荧光分析中8.1%的MS血清识别皮肤基底膜;全长BP180 ELISA分析中7.5%的MS和AD血清阳性。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Neurologic patients have an increased risk for bullous pemphigoid (BP), in which autoantibodies target BP180, a cutaneous basement membrane protein also expressed in the brain. Here we show that 53.6% of sera from patients with multiple sclerosis (MS) (n = 56) had IgG reactivity against full-length BP180 in immunoblotting, while in BP180 non-collagenous 16A ELISA (n = 143), only 7.7% of MS samples studied were positive. Epitope mapping with 13 fusion proteins covering the entire BP180 polypeptide revealed that in MS and Alzheimer's disease (AD) patients, IgG autoantibodies target regions located in the intracellular and mid-extracellular parts of BP180, but not the well-known BP epitopes located in the non-collagenous 16A domain and the distal part of extracellular domain. In indirect immunofluorescence analysis, 8.1% of MS sera recognized the cutaneous basement membrane and in full-length BP180 ELISA analysis, 7.5% MS and AD sera were positive, indicating that these autoantibodies rarely recognize BP180 in its native conformation. Thus, in MS and AD patients, BP180 autoantibodies have a different epitope profile than in patients with BP, and seldom bind to native BP180. This explains the inability of these autoantibodies to cause skin symptoms. Our results suggest that the autoantibodies against BP180 alone are not sufficient to induce BP in MS and AD patients.
引用
- Tuusa J, Lindgren O, Tertsunen HM, et al. BP180 Autoantibodies Target Different Epitopes in Multiple Sclerosis or Alzheimer's Disease than in Bullous Pemphigoid. J Invest Dermatol. 2018. PMID: 30315782. doi:10.1016/j.jid.2018.09.010
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。